Affiliation:
1. 1School of Chemical Engineering, The Key Laboratory for Surface Engineering and Remanufacturing in Shaanxi Province, Xi’an University, Xi’an, China
2. 2Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
Abstract
AbstractC19H18Br2O4, monoclinic, P21/n (no. 14), a = 14.323(3) Å, b = 7.6704(17) Å, c = 17.112(4) Å, β = 111.948(4)°, V = 1743.7(7) Å3, Z = 4, Rgt(F) = 0.0530, wRref(F2) = 0.1219, T = 296(2) K.
Funder
National Natural Science Foundation of China
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Reference12 articles.
1. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors;Eur. J. Med. Chem.,2001
2. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors;Eur. J. Med. Chem.,2001
3. Plasma protein binding properties of dimeric 4-aryl-1,4-dihydropyridines as novel non peptidic HIV-1 protease inhibitors;Pharmazie,2000
4. Novel solid-state synthesis of dimeric 4-aryl-1,4-dihydropyridines;J. Heterocycl. Chem.,1998
5. Novel solid-state synthesis of dimeric 4-aryl-1,4-dihydropyridines;J. Heterocycl. Chem.,1998